← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Western Institute For Veterans Research
Salt Lake City, UT
$20,991,058
Total funding
16
Grants
Funding over time
peak $5.7M · FY2006–25$10M$7.5M$5M$2.5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
DOD$19,975,854 · 13
AHRQ$539,830 · 1
NIH$475,374 · 2
By mechanism
—$19,975,854 · 13
R18$539,830 · 1
R21$375,300 · 1
F32$100,074 · 1
Investigators at Western Institute For Veterans Research
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
SHINING LIGHT ON TRAUMA: TREATMENT OF CHRONIC TBI TO IMPROVE PSYCHOLOGICAL HEALTH USING PHOTOBIOMODULATION IN SERVICE MEMBERS, VETERANS AND FIRST RESPONDERS$4,613,247
· FY2025 · Defense Health Agency
MILITARY INJURIES - UNDERSTANDING POST-TRAUMATIC EPILEPSY (MINUTE): BIOINFORMATICS WITH BIG DATA TO EXAMINE MULTIMODAL PTE BIOMARKERS$3,099,990
· FY2021 · Department of the Army
DEVELOPMENT OF OSSEOINTEGRTED IMPLANTS FOR SOLDIER AMPUTEES FOLLOWING ORTHOPAEDIC EXTRMEITY TRAUMA$3,079,072
· FY2008 · Department of the Army
EARLY RECOGNITION OF UNDIAGNOSED VIRAL SYNDROMES AND THEIR PREDICTORS OVER TIME$1,859,430
· FY2022 · Department of the Army
POSITIONED (PRECISION, STANDARDIZATION AND ORGANIZATIONAL READINESS IN TBI CARE)$1,499,863
· FY2022 · Defense Health Agency
FUNCTIONAL OUTCOMES AND BIOMARKERS IN OCCUPATIONAL BLAST EXPOSURE (FOB: OBE): THE IMPACT ON SERVICE MEMBERS, VETERANS, AND THEIR FAMILIES$1,051,179
· FY2025 · Defense Health Agency
PROBIOTIC (BIFIDOBACTERIUM INFANTIS) FOR GULF WAR ILLNESS$932,520
· FY2010 · Defense Health Agency
FLUORHYDROXYAPATITE COATINGS FOR FACILITATING EPITHELIAL CELLS ADHESION TO THE IMPLANT SURFACE FOR PREVENTING INFECTION IN PERCUTANEOUS IMPLANT SYSTE$749,864
· FY2015 · Department of Defense
ATTAINING A BIOLOGICALLY STABLE STOMA AT THE IMPLANT EXIT SITE OF A PERCUTANEOUS OSSEOINTEGRATED PROSTHESIS.$724,998
· FY2021 · Defense Health Agency
INTRACEPTOR INTERFERENCE OF VEGF PATHWAYS IN CORNEAL ANGIOGENSIS$718,750
· FY2008 · Department of the Army
PHENOTYPES OF COMORBIDITY IN EPILEPSY: VARIATION BY TBI SEVERITY AND DEPLOYMENT STATUS$572,809
· FY2018 · Defense Health Agency
HOME AND COMMUNITY BASED SERVICE USE AND PREFERENCES AMONG POST 9 11 VETERANS AT HIGH RISK OF ALZHEIMERS DISEASE AND RELATED DEMENTIA AND THEIR CAREGIVERS$549,575
· FY2022 · Defense Health Agency
EFFECT OF DIET ON GULF WAR ILLNESS: A PILOT STUDY$524,557
· FY2015 · Defense Health Agency
VA Integrated Medication Manager$239,030
R18 · FY2007 · HS
Potential Therapeutic Applications of Ecto-Nucleotidases in Lithium-induced NDI$208,900
R21 · FY2009 · DK
VA Integrated Medication Manager$193,127
R18 · FY2008 · HS
Potential Therapeutic Applications of Ecto-Nucleotidases in Lithium-induced NDI$166,400
R21 · FY2010 · DK
VA Integrated Medication Manager$107,673
R18 · FY2009 · HS
Migration of Cajal-Retzius cells$51,278
F32 · FY2007 · HD
Migration of Cajal-Retzius cells$48,796
F32 · FY2006 · HD